Scientists from UNSW Sydney and the UK have discovered that the human immunodeficiency virus (HIV) hijacks a small molecule from the host cell to protect itself from being destroyed by the host's immune system.
Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial and in rhesus monkeys
The mosaic Ad26/Ad26 plus gp140 HIV-1 vaccine induced comparable and robust immune responses in humans and rhesus monkeys, and it provided significant protection against repetitive heterologous SHIV challenges in rhesus monkeys. This vaccine concept is currently being evaluated in a phase 2b clinical efficacy study ...
Interview with Dr. Arash Alaei, consultant and Director of the International Institute for Health and Education
An experimental vaccine for HIV is set to be tried on humans in 2019.
Fear of others thinking they’re promiscuous, or that they’re already infected with HIV, is a barrier to many women who might benefit from pills that help prevent the infection, a U.S. study suggests.
Last December, Ministry of Social Affairs and National Institute for Health Development from Estonia, WHO European Region, UNAIDS and the Global Fund organised a two day meeting on challenges and opportunities in national HIV and TB programmes management.
Taking large numbers of non-ART drugs associated with increased risk of hospitalisation and death for HIV-positive people
Taking large numbers of medications in addition to antiretroviral therapy (ART) is associated with an increased risk of hospitalisation and death for HIV-positive individuals, investigators from the US Department of Veterans Affairs report in AIDS.
Self-testing for HIV with rapid diagnostic tests is as reliable and accurate as testing by health care workers, according to a new review and meta-analysis.
Despite the prevalence of depression in people with HIV (estimates of up to 42%), few data exist on antidepressant efficacy in this population. Previous studies of depression in people with HIV have tended to be from American men who have sex with men. As a ...
As it became known to the media, an HIV-positive patient died from AIDS in Switzerland in the end of 2017. He was being refused of a medical treatment due to missing necessary health insurance, and the insurance company refused several times to pay for the ...
The number of HIV patients that underwent treatment in Q1 2018 did not change in Latvia even though a considerable amount of funding was allocated from the state budget for HIV/AIDS treatment in 2018. This creates concerns about HIV patients’ use of healthcare services, according ...
Ageing with HIV: New challenges and unmet needs of people aged 18 – 50 years living and ageing with HIV/AIDS (3-6 May 2018, Kyiv)
For 6 years in the Russian Federation, 178 permits have been issued for the clinical trials of medications for the treatment and prevention of HIV/AIDS. This is seven times more than in the previous six years, from 2006 to 2011, when 25 studies were approved. While ...
EECA is one of two regions where transition planning is most advanced
No disease has the same level of timely and accurate data collection, analysis and distribution as HIV. With credible and up-to-date data, countries and the international community can plan effective AIDS responses. They can focus services on the locations and populations that most need them, ...
The #YouAreNotAlone campaign is raising awareness about the stigma and discrimination faced by children, adolescents and families affected by HIV in eastern Europe and central Asia.
A new campaign highlights the health issues that can affect us as we get older - and which HIV positive people need to be aware about
Therapies to prevent infection are advancing in a crowded field.